Molecular Cytogenetics of Autism
Journal:
Current Genomics
Volume:
5
Page:
347-364
Author(s):
Jie Xu, Lonnie Zwaigenbaum, Peter Szatmari and Stephen W. Scherer
Cellular Targets for Anticancer Strategies
Journal:
Current Drug Targets
Volume:
5
Page:
347-355
Author(s):
Caterina A.M. La Porta
Sphingolipid Metabolism Enzymes as Targets for Anti-Cancer Therapy
Journal:
Current Drug Targets
Volume:
5
Page:
375-382
Author(s):
J. W. Kok and H. Sietsma
Molecular Targeting of Drug Delivery Systems to Cancer
Journal:
Current Drug Targets
Volume:
5
Page:
389-406
Author(s):
T. Minko, S. S. Dharap, R. I. Pakunlu and Y. Wang
Regulation of Calcium Signaling by the Second Messenger Cyclic Adenosine Diphosphoribose (cADPR)
Journal:
Current Molecular Medicine
Volume:
4
Page:
239-248
Author(s):
Andreas H. Guse
New Insights into Serotonin 5-HT4 Receptors : A Novel Therapeutic Target for Alzheimers Disease?
Journal:
Current Alzheimer Research
Volume:
1
Page:
79-85
Author(s):
Marjorie Maillet, Sylvain J. Robert and Frank Lezoualc'h
Amine Oxidase Inhibitors and Development of Neuroprotective Drugs
Journal:
Current Neuropharmacology
Volume:
2
Page:
153-168
Author(s):
Bernard N. Sowa, Kathryn G. Todd, A. M. I Tanay, Andrew Holt and Glen B. Baker
P2Y Receptor Activation Affects the Proliferation and Differentiation of Glial and Neuronal Cells: A Focus on Rat C6 Glioma Cells
Journal:
Current Neuropharmacology
Volume:
2
Page:
207-220
Author(s):
Patrik Claes and Herman Slegers
Nonnucleoside Inhibitors of Adenosine Kinase
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1093-1103
Author(s):
Arthur Gomtsyan and Chih-Hung Lee
Islet-Brain (IB)/JNK-Interacting Proteins (JIPs): Future Targets for the Treatment of Neurodegenerative Diseases?
Journal:
Current Neurovascular Research
Volume:
1
Page:
111-127
Author(s):
Nathalie Moulin and Christian Widmann